536
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

General practitioners’ role in safeguarding patients with dementia in their use of dietary supplements. A qualitative study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 16-28 | Received 09 Sep 2022, Accepted 08 Nov 2023, Published online: 20 Nov 2023

References

  • U.S. Department of Health & Human Services. Dietary supplement health and education act of 1994. Public law no. 103-417. Paragraph 3a. Department of Health & Human Services; National Institute of Health; 1994.
  • Starr RR. Too little, too late: ineffective regulation of dietary supplements in the United States. Am J Public Health. 2015;105(3):478–485. doi: 10.2105/AJPH.2014.302348.
  • Bailey RL, Gahche JJ, Miller PE, et al. Why US adults use dietary supplements. JAMA Intern Med. 2013;173(5):355–361. doi: 10.1001/jamainternmed.2013.2299.
  • Chiba T, Sato Y, Nakanishi T, et al. Inappropriate usage of dietary supplements in patients by miscommunication with physicians in Japan. Nutrients. 2014;6(12):5392–5404. doi: 10.3390/nu6125392.
  • Persson T, Popescu BO, Cedazo-Minguez A. Oxidative stress in Alzheimer’s disease: why did antioxidant therapy fail? Oxid Med Cell Longev. 2014;2014:427318. doi: 10.1155/2014/427318.
  • Rutjes AW, Denton DA, Di Nisio M, et al. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. Cochrane Database Syst Rev. 2018;12(12):CD011906. doi: 10.1002/14651858.CD011906.pub2.
  • Burckhardt M, et al. Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst Rev. 2016;4(4):Cd009002.
  • Chan ES, et al. Traditional Chinese herbal medicine for vascular dementia. Cochrane Database Syst Rev. 2018;12(12):Cd010284.
  • The Norwegian Directorate of Health. Personer med demens bør ikke tilbys betennelsesdempende legemidler, statiner, kosttilskudd eller naturpreparater mot demens/APSD. 2022 May 11 [cited 2022 Aug 11; web page]. Available from: https://www.helsedirektoratet.no/retningslinjer/demens/betennelsesdempende-legemidler-statiner-kosttilskudd-eller-naturpreparater-mot-demens-apsd/personer-med-demens-bor-ikke-tilbys-betennelsesdempende-legemidler-statiner-kosttilskudd-eller-naturpreparater-mot-demens-apsd.
  • Landin J, Frolich L, Schwarz S. Use of alternative therapies in patients with dementia and mild cognitive impairment: a prospective, controlled study. Int J Geriatr Psychiatry. 2008;23(11):1163–1165. doi: 10.1002/gps.2046.
  • Risvoll H, Giverhaug T, Halvorsen KH, et al. Direct and indirect risk associated with the use of dietary supplements among persons with dementia in a Norwegian memory clinic. BMC Complement Altern Med. 2017;17(1):261. doi: 10.1186/s12906-017-1765-5.
  • Cross AJ, George J, Woodward MC, et al. Dietary supplement use in older people attending memory clinics in Australia. J Nutr Health Aging. 2017;21(1):46–50. doi: 10.1007/s12603-016-0742-x.
  • Djuv A, Nilsen OG, Steinsbekk A. The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study. BMC Complement Altern Med. 2013;13(1):295. doi: 10.1186/1472-6882-13-295.
  • Gardiner P, Sadikova E, Filippelli AC, et al. Medical reconciliation of dietary supplements: don’t ask, don’t tell. Patient Educ Couns. 2015;98(4):512–517. doi: 10.1016/j.pec.2014.12.010.
  • Parvez MK, Rishi V. Herb-drug interactions and hepatotoxicity. Curr Drug Metab. 2019;20(4):275–282. doi: 10.2174/1389200220666190325141422.
  • Hamishehkar H, Ranjdoost F, Asgharian P, et al. Vitamins, are they safe? Adv Pharm Bull. 2016;6(4):467–477. doi: 10.15171/apb.2016.061.
  • Cohen PA, Avula B, Wang YH, et al. Five unapproved drugs found in cognitive enhancement supplements. Neurol Clin Pract. 2021;11(3):e303–e307. doi: 10.1212/CPJ.0000000000000960.
  • Wardle JL, Adams J. Indirect and non-health risks associated with complementary and alternative medicine use: an integrative review. Eur J. Integr Med. 2014;6(4):409–422. doi: 10.1016/j.eujim.2014.01.001.
  • Hasvold T, Christensen B, et al. Building primary care in a changing Europe: case studies (internet). In: Kringos DS, editor. European observatory on health systems and policies. Copenhagen (Denmark): WHO Regional Office for Europe; 2015. PMID:29064645.
  • GjØra L, Strand BH, Bergh S, et al. Current and future prevalence estimates of mild cognitive impairment, dementia, and its subtypes in a population-based sample of people 70 years and older in Norway: the HUNT study. J Alzheimers Dis. 2021;79(3):1213–1226. doi: 10.3233/JAD-201275.
  • Al-Azzawi R, Halvorsen PA, Risør T. Context and general practitioner decision-making - a scoping review of contextual influence on antibiotic prescribing. BMC Fam Pract. 2021;22(1):225. doi: 10.1186/s12875-021-01574-x.
  • Boustani M, Schubert C, Sennour Y. The challenge of supporting care for dementia in primary care. Clin Interv Aging. 2007;2(4):631–636.
  • Tarn DM, Paterniti DA, Good JS, et al. Physician-patient communication about dietary supplements. Patient Educ Couns. 2013;91(3):287–294. doi: 10.1016/j.pec.2013.01.021.
  • Risvoll H, Musial F, Halvorsen KH, et al. Pharmacy employees’ involvement in safeguarding persons with dementia who use dietary supplements: results from a survey of Norwegian pharmacies. BMC Complement Altern Med. 2019;19(1):179. doi: 10.1186/s12906-019-2587-4.
  • Risvoll H, Musial F, Waaseth M, et al. Home care service employees’ contribution to patient safety in clients with dementia who use dietary supplements: a Norwegian survey. Scand J Prim Health Care. 2021;39(4):403–412. doi: 10.1080/02813432.2021.1970944.
  • Thorsnæs G. Nord Norge (North Norway). Store norske leksikon (The Great Norwegian Encyclopedia) [cited 2023 Feb 23]. Available from: https://snl.no/Nord-Norge.
  • Malterud K. Systematic text condensation: a strategy for qualitative analysis. Scand J Public Health. 2012;40(8):795–805. doi: 10.1177/1403494812465030.
  • Illich I. Medical nemesis. Lancet. 1974;1(7863):918–921.
  • Johnell K, Fastbom J. Multi-dose drug dispensing and inappropriate drug use: a nationwide register-based study of over 700 000 elderly. Scand J Prim Health Care. 2008;26(2):86–91. doi: 10.1080/02813430802022196.
  • Tabet N, Khan R, Idle H. Vitamin and herbal extracts use in patients diagnosed with dementia: what do health professionals know and think? Aging Ment Health. 2011;15(2):267–271. doi: 10.1080/13607863.2010.513040.
  • Fadlon I, Van Parys J. Primary care physician practice styles and patient care: evidence from physician exits in medicare. J Health Econ. 2020;71:102304. doi: 10.1016/j.jhealeco.2020.102304.
  • Cham G, Davis N, Strivens E, et al. Factors correlating to the propensity of general practitioners to substitute borderline vitamin B12 deficiency. Scand J Prim Health Care. 2018;36(3):242–248. doi: 10.1080/02813432.2018.1487522.
  • Hayward RA, Asch SM, Hogan MM, et al. Sins of omission: getting too little medical care may be the greatest threat to patient safety. J Gen Intern Med. 2005;20(8):686–691. doi: 10.1111/j.1525-1497.2005.0152.x.
  • Liu L, Tang Y, Baxter GD, et al. Complementary and alternative medicine - practice, attitudes, and knowledge among healthcare professionals in New Zealand: an integrative review. BMC Complement Med Ther. 2021;21(1):63. doi: 10.1186/s12906-021-03235-z.
  • Han PK, Klein WM, Arora NK. Varieties of uncertainty in health care: a conceptual taxonomy. Med Decis Making. 2011;31(6):828–838. doi: 10.1177/0272989X10393976.
  • Ellsberg D. Risk, ambiguity, and the savage axioms. Q J Econ. 1961;75(4):643–669. doi: 10.2307/1884324.
  • Pitkälä KH, Suominen MH, Bell JS, et al. Herbal medications and other dietary supplements. A clinical review for physicians caring for older people. Ann Med. 2016;48(8):586–602. doi: 10.1080/07853890.2016.1197414.
  • Maha N, Shaw A. Academic doctors’ views of complementary and alternative medicine (CAM) and its role within the NHS: an exploratory qualitative study. BMC Complement Altern Med. 2007;7(1):17. doi: 10.1186/1472-6882-7-17.
  • Jureidini J, McHenry LB. The illusion of evidence based medicine. BMJ. 2022;376:o702. doi: 10.1136/bmj.o702.
  • Lexchin J. Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications. Sci Eng Ethics. 2012;18(2):247–261. doi: 10.1007/s11948-011-9265-3.
  • Ostermaier A, Barth N, Linde K. How German general practitioners justify their provision of complementary and alternative medicine - a qualitative study. BMC Complement Med Ther. 2020;20(1):111. doi: 10.1186/s12906-020-02907-6.